New guidance for clinicians on COVID-19 in patients with haemoglobinopathies and inherited rare anaemias.

Written By Guest User

Updated guidance has been produced by the Haemoglobinopathy Co-Ordinating Centres and NHP on the management of COVID-19 in haemoglobinopathy patients in light of the second UK national lockdown that commenced on 5th November. Click the link below to read the document.

Guest User
Previous

NHP Publishes Guideline for use of Crizanlizumab

Next

Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic